| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.09 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |